Pharma Focus Asia

Press Releases

Archives - 2009

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Archives - 2010

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

March 2009

Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia

Tuesday 31 Mar, 2009

Immunotech Completes Merger Acquisition

Monday 30 Mar, 2009

Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research

Sunday 29 Mar, 2009

MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow UpMitraClip(R) Therapy Data Shows Important Clinical Benefit in

Saturday 28 Mar, 2009

Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure

Friday 27 Mar, 2009

Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced

Friday 20 Mar, 2009

Ym Biosciences Announces First Patient Enrolled In Multi-National, Randomized, Double-Blind Trial? Of Nimotuzumab In Non-Small-Cell Lung Cancer

Monday 16 Mar, 2009

C1-Esterase Inhibitor Concentrate Rapidly Relieves Acute Swelling Attacks Across All Body Sites in Patients with Hereditary Angioedema, According to Study

Sunday 15 Mar, 2009

New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits

Saturday 14 Mar, 2009

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

Friday 13 Mar, 2009

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

Thursday 12 Mar, 2009

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

Wednesday 11 Mar, 2009

Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically

Thursday 5 Mar, 2009

Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions

Tuesday 3 Mar, 2009

Hi-Tech Pharmacal Acquires ECR Pharmaceuticals

Monday 2 Mar, 2009


ochremedia © 2010 Ochre Media. All rights reserved.